Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+4 prostate cancer

被引:37
作者
Gondo, Tatsuo [1 ,2 ]
Hricak, Hedvig [3 ]
Sala, Evis [3 ]
Zheng, Junting [4 ]
Moskowitz, Chaya S. [4 ]
Bernstein, Melanie [1 ]
Eastham, James A. [1 ]
Vargas, Hebert Alberto [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[2] Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan
[3] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
关键词
Prostate cancer; Active surveillance; Multiparametric MRI; Diffusion-weighted imaging; Dynamic contrast-enhanced MRI; ACTIVE SURVEILLANCE; LOW-RISK; GRADE; INTERMEDIATE; CANDIDATES; AGREEMENT; OUTCOMES; UPDATE; SYSTEM; MEN;
D O I
10.1007/s00330-014-3367-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to assess the diagnostic performance of pre-treatment 3-Tesla (3T) multiparametric magnetic resonance imaging (mpMRI) for predicting Gleason score (GS) downgrading after radical prostatectomy (RP) in patients with GS 3 + 4 prostate cancer (PCa) on biopsy. We retrospectively reviewed 304 patients with biopsy-proven GS 3 + 4 PCa who underwent mpMRI before RP. On T2-weighted imaging and three mpMRI combinations (T2-weighted imaging + diffusion-weighted imaging [DWI], T2-weighted imaging + dynamic contrast-enhanced-MRI [DCE-MRI], and T2-weighted imaging + DWI + DCE-MRI), two radiologists (R1/R2) scored the presence of a dominant tumour using a 5-point Likert scale (1 = definitely absent to 5 = definitely present). Diagnostic performance in identifying downgrading was evaluated via areas under the curves (AUCs). Predictive accuracies of multivariate models were calculated. In predicting downgrading, T2-weighted imaging + DWI (AUC = 0.89/0.85 for R1/R2) performed significantly better than T2-weighted imaging alone (AUC = 0.72/0.73; p < 0.001/p = 0.02 for R1/R2), while T2-weighted imaging + DWI + DCE-MRI (AUC = 0.89/0.84 for R1/R2) performed no better than T2-weighted imaging + DWI (p = 0.48/p > 0.99 for R1/R2). On multivariate analysis, the clinical + mpMRI model incorporating T2-weighted imaging + DWI (AUC = 0.92/0.88 for R1/R2) predicted downgrading significantly better than the clinical model (AUC = 0.73; p < 0.001 for R1/R2). mpMRI improves the ability to identify a subgroup of patients with Gleason 3 + 4 PCa on biopsy who are candidates for active surveillance. DCE-MRI (compared to T2 + DWI) offered no additional benefit to the prediction of downgrading. aEuro cent Diagnostic performance of T2-weighted-imaging + DWI was better than T2-weighted-imaging alone. aEuro cent Diagnostic performance of T2-weighted-imaging + DWI was similar to T2-weighted-imaging + DWI + DCE-MRI. aEuro cent Combining clinical and T2-weighted-imaging + DWI features best predicted GS downgrading. aEuro cent mpMRI might prevent overtreatment by increasing eligibility for PCa active surveillance.
引用
收藏
页码:3161 / 3170
页数:10
相关论文
共 32 条
[1]  
Adam M, 2014, J UROL
[2]   ESUR prostate MR guidelines 2012 [J].
Barentsz, Jelle O. ;
Richenberg, Jonathan ;
Clements, Richard ;
Choyke, Peter ;
Verma, Sadhna ;
Villeirs, Geert ;
Rouviere, Olivier ;
Logager, Vibeke ;
Futterer, Jurgen J. .
EUROPEAN RADIOLOGY, 2012, 22 (04) :746-757
[3]   Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing [J].
Bjurlin, Marc A. ;
Carter, H. Ballentine ;
Schellhammer, Paul ;
Cookson, Michael S. ;
Gomella, Leonard G. ;
Troyer, Dean ;
Wheeler, Thomas M. ;
Schlossberg, Steven ;
Penson, David F. ;
Taneja, Samir S. .
JOURNAL OF UROLOGY, 2013, 189 (06) :2039-2046
[4]   Does Suspicion of Prostate Cancer on Integrated T2 and Diffusion-weighted MRI Predict More Adverse Pathology on Radical Prostatectomy? [J].
Borofsky, Michael S. ;
Rosenkrantz, Andrew B. ;
Abraham, Nitya ;
Jain, Rajat ;
Taneja, Samir S. .
UROLOGY, 2013, 81 (06) :1279-1283
[5]   Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer [J].
Bul, Meelan ;
van den Bergh, Roderick C. N. ;
Zhu, Xiaoye ;
Rannikko, Antti ;
Vasarainen, Hanna ;
Bangma, Chris H. ;
Schroder, Fritz H. ;
Roobol, Monique J. .
BJU INTERNATIONAL, 2012, 110 (11) :1672-1677
[7]   Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer [J].
Cooperberg, Matthew R. ;
Cowan, Janet E. ;
Hilton, Joan F. ;
Reese, Adam C. ;
Zaid, Harras B. ;
Porten, Sima P. ;
Shinohara, Katsuto ;
Meng, Maxwell V. ;
Greene, Kirsten L. ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) :228-234
[8]   Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Prostate Cancer after Radiation Therapy? [J].
Donati, Olivio F. ;
Jung, Sung Il ;
Vargas, Hebert Alberto ;
Gultekin, David H. ;
Zheng, Junting ;
Moskowitz, Chaya S. ;
Hricak, Hedvig ;
Zelefsky, Michael J. ;
Akin, Oguz .
RADIOLOGY, 2013, 268 (02) :440-450
[9]   Poorly differentiated prostate cancer treated with radical prostatectomy: Long-term outcome and incidence of pathological downgrading [J].
Donohue, John F. ;
Bianco, Fernando J., Jr. ;
Kuroiwa, Kentaro ;
Vickers, Andrew J. ;
Wheeler, Thomas M. ;
Scardino, Peter T. ;
Reuter, Victor A. ;
Eastham, James A. .
JOURNAL OF UROLOGY, 2006, 176 (03) :991-995
[10]   A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer [J].
Eggener, Scott E. ;
Mueller, Alex ;
Berglund, Ryan K. ;
Ayyathurai, Raj ;
Soloway, Cindy ;
Soloway, Mark S. ;
Abouassaly, Robert ;
Klein, Eric A. ;
Jones, Steven J. ;
Zappavigna, Chris ;
Goldenberg, Larry ;
Scardino, Peter T. ;
Eastham, James A. ;
Guillonneau, Bertrand .
JOURNAL OF UROLOGY, 2013, 189 (01) :S19-S25